Matsuda Akira | Graduate School of Pharmaceutical Sciences, Hokkaido University

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Antitumor Activity and Pharmacokinetics of TAS-106, 1-(3-C-Ethyny1-β-D-ribo-pentofuranosyl)cytosine
P-253 DEVELOPMENT OF POTENT HISTAMINE H_3 AND/OR H_4 RECEPTOR ANTAGONISTS BY THE STEREOCHEMICAL DIVERSITY-ORIENTED CONFORMATIONAL RESTRICTION STRATEGY
Conformational Analysis of the NMDA Receptor Antagonist (1S,2R)-1-Phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) Designed by a Novel Conformational Restriction Method Based on the Structural Feature of Cyclopronane Ring
Synthesis of Conformationally Restricted Analogs of Baclofen, a Potent GABA_B Receptor Agonist, by the Introduction of a Cyclopropane Ring
Nucleosides and Nucleotides. 186. Synthesis and Biological Activities of Pyrimidine Carbocyclic Nucleosides with a Hydroxyamino Group Instead of a Hydroxymethyl Group at the 4'-Position of the Sugar Moiety
Mutagenicity of 5-Formylcytosine, an Oxidation Product of 5-Methylcytosine, in DNA in Mammalian Cells
Crystallographic Studies on Damaged DNAs : III. N^4-Methoxycytosine Can Form Both Watson-Crick Type and Wobbled Base Pairs in a B-Form Duplex^1
Sensitivity, of Human Cancer Cells to the New Anticancer Ribo-nucleoside TAS-106 Is Correlated with Expression of Uridine-cytidine Kinase 2
Cellular and Biochemical Mechanisms of the Resistance of Human Cancer Cells to a New Anticancer Ribo-nucleoside, TAS-106
(1S,2R)-1-Phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PRDC), a New Class of NMDA-Receptor Antagonist: Molecular Design by a Novel Conformational Restriction Strategy
P-530 Synthetic Study of the Stable Analog of Chitin Synthase Inhibitors, Guanofosfosins

もっと見る

スポンサーリンク